Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS [Phase 2]
Phase 2 study evaluating JYP0015 in advanced solid tumors with RAS mutations is currently recruiting, including pancreatic ductal adenocarci…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway [Phase 1]
Phase 1 trial of DCC-3084 for MAPK-pathway driven advanced cancers has been terminated. The update notes the study status without presenting…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating TJ033721 (Givastomig) in adults with advanced or metastatic solid tumors; the study is currently recruiting and inc…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating STRO-004 in adults with refractory or recurrent metastatic cancer is currently recruiting, investigating…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
This is a Phase 3 clinical trial evaluating chiauranib in combination with a PD-1 inhibitor, albumin-bound paclitaxel, and gemcitabine for m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer [Phase 2]
A Mayo Clinic–sponsored Phase 2 trial evaluating standard chemotherapy with or without stereotactic body radiation therapy for oligometastat…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: How Does Pre-operative Biliary Drainage in Pancreatic Adenocarcinoma Affect Surgical Outcomes in Pancreatic Cancer Surgery
This ClinicalTrials.gov entry describes a study on whether pre-operative biliary drainage influences surgical outcomes in pancreatic ductal …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Targeted Pathway Inhibition in Patients With Pancreatic Cancer [EARLY_Phase 1]
An early-phase (Phase 1) trial of a targeted pathway inhibitor for pancreatic ductal adenocarcinoma is currently recruiting, enrolling patie…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 clinical trial evaluating EDV Nanocell Therapy in combination with gemcitabine and nab-pacli…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Clinical trial update for IN10018 in combination with RNK08954 for KRASG12D mutation-positive locally advanced or metastatic solid tumors; t…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is recruiting to evaluate a combination therapy for localized pancreatic ductal adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1, Phase 2]
An ongoing Phase 1/2 trial evaluating pancrelipase in metastatic pancreatic ductal adenocarcinoma. The study is currently active but not rec…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for tegavivint in recurrent or refractory solid tumors, including lymphomas and desmoid tumors, currently …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of AZD5863 in adults with advanced or metastatic solid tumors is currently recruiting, including gastric cancer, gastroeso…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1]
This entry notes an ongoing Phase 1 trial evaluating an MK2 inhibitor in combination with mFOLFIRINOX for untreated metastatic pancreatic du…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Pancreatic Adenocarcinoma Signature Stratification for Treatment [Phase 2]
Phase 2 pancreatic cancer trial focusing on signature-based stratification for treatment. The study status is completed.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers [NA]
Clinical trial evaluating early multigene sequencing for theranostics in advanced cancers to guide therapy, across breast cancer, hepatocell…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC [NA]
This clinical trial update describes an early feasibility study evaluating YntraDose as a neoadjuvant treatment for locally advanced, unrese…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer [NA]
This clinical trial update notes a recruiting study evaluating a brief psychological intervention to improve emotional well-being during neo…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update details a biomarker-guided allogeneic CAR-NK cell therapy using single-target or dual-target constructs for advan…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures [NA]
A clinical trial is investigating personalized first-line chemotherapy choices for advanced pancreatic ductal adenocarcinoma using tumor tra…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy [Phase 2]
This is a phase 2 clinical trial update on pembrolizumab plus olaparib for metastatic pancreatic ductal adenocarcinoma with homologous recom…
-
CLINICAL_TRIALS other · 2026-02-18Clinical Trial Update: Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC
Expanded Access update for mifomelatide in adults with advanced pancreatic ductal adenocarcinoma to address cancer cachexia; the program is …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations [Phase 2]
A Phase II nationwide, fully decentralized telemedicine study of pemigatinib for adults with FGFR-altered advanced or metastatic pancreatic …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer [NA]
Clinical trial update indicating ongoing recruitment for Nano-Megestrol Acetate to treat cancer cachexia in patients with advanced pancreati…